PTA |
Percutaneous Thermal Ablation |
HCC |
Hepatocellular Carcinoma |
BCLC |
Barcelona Clinic Liver Cancer |
US |
Ultrasonography |
RFS |
Recurrence-Free Survival |
AFP |
Alpha-Fetoprotein |
OS |
Overall Survival |
MELD |
Model for End-Stage Liver Disease |
NAFLD |
Non-Alcoholic Fatty Liver Disease |
ECOG |
Eastern Cooperative Oncology Group |
AASLD |
American Association for the Study of Liver Disease |
EASL |
European Association for the Study of the Liver |
BMI |
Body Mass Index |
ALBI |
Albumin–Bilirubin |
MRI |
Magnetic Resonance Imaging |
ASA |
American Society of Anesthesiologists |
CT |
Computed Tomography |
SIR |
Society of Interventional Radiology |
LTP |
Local tumor progression |
SD |
Standard Deviation |
IQR |
Interquartile Range |
AIC |
Akaike Information Criterion |
TACE |
Transarterial Chemoembolization |
OR |
Odds Ratio |
CI |
Confidence Interval |
HR |
Hazard Ratio |
NASH |
Non-Alcoholic Steatohepatitis |